Business

British regulator approves AstraZeneca to acquire Alexion for US$39 billion by Reuters

[ad_1]

2/2

© Reuters. File photo: On March 22, 2021, the AstraZeneca logo can be seen outside the North American headquarters in Wilmington, Delaware, USA. REUTERS/Rachel Wisniewski

2/2

(Reuters)-The British competition regulator said on Wednesday that it has approved AstraZeneca (NASDAQ:) to acquire US-based Alex Brothers (NASDAQ:) for US$39 billion. The company decided not to conduct a more extensive investigation of the transaction after the initial assessment.

The Competition and Markets Authority began reviewing whether planned acquisitions would reduce competition in the UK or other markets in May. Its customs clearance was obtained from Europe earlier this month.

Disclaimer: Converged Media I would like to remind you that the data contained on this website may not be real-time or accurate. All CFDs (stocks, indices, futures) and foreign exchange prices are not provided by exchanges, but by market makers. Therefore, prices may be inaccurate and may be different from actual market prices. This means that prices are indicative and not Suitable for trading purposes. Therefore, Fusion Media is not responsible for any transaction losses that you may suffer as a result of using this data.

Converged Media Fusion Media or anyone related to Fusion Media will not be liable for any loss or damage caused by relying on the data, quotations, charts, and buy/sell signals contained in this website. Please fully understand the risks and costs associated with financial market transactions. This is one of the most risky forms of investment.



[ad_2]

Source link

Related